High-throughput optofluidic screening of single B cells identifies novel cross-reactive antibodies as inhibitors of uPAR with antibody-dependent effector functions
The urokinase-type plasminogen activator receptor (uPAR) is an essential regulator for cell signaling in tumor cell proliferation, adhesion, and metastasis. The ubiquitous nature of uPAR in many aggressive cancer types makes uPAR an attractive target for immunotherapy. Here, we present a rapid and s...
Saved in:
Main Authors: | André Luiz Lourenço, Shih-Wei Chuo, Markus F. Bohn, Byron Hann, Shireen Khan, Neha Yevalekar, Nitin Patel, Teddy Yang, Lina Xu, Dandan Lv, Robert Drakas, Sarah Lively, Charles S. Craik |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | mAbs |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2023.2184197 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potentiating Antibody-Dependent Cellular Cytotoxicity in Triple-Negative Breast Cancer via the Humanized Anti-CD147 Antibody
by: Kanyarat Thongheang, et al.
Published: (2025-04-01) -
Indicators of the fibrinolytic system in the blood and cerebrospinal fluid of patients with metastatic brain lesions
by: L. A. Goroshinskaya, et al.
Published: (2025-03-01) -
Trispecific SEED antibodies engineered for neutrophil-mediated cell killing
by: Veronica Natale, et al.
Published: (2025-12-01) -
Influenza-specific antibody-mediated and complement-dependent cellular cytotoxicity-inducing antibodies in vaccinated and infected pigs
by: Mithilesh Singh, et al.
Published: (2025-06-01) -
Proteolytic enzyme and adiponectin receptors as potential targets for COVID-19 therapy
by: K. A. Rubina, et al.
Published: (2021-05-01)